OM1

Predict What's Next. Improve Outcomes.

Boston, United States · Founded 2015

Employees
51–200
Founded
2015
Business Model
B2B
Website
om1.com
Last Round
Series DJul 2021
Rounds
4

About

OM1 is an AI-powered real-world data platform that helps life sciences companies, healthcare providers, and payers generate evidence and predict patient outcomes. Its PhenOM foundation model, trained on over 1 billion patient-years, powers digital phenotyping, medical event prediction, and automated clinical registries. The company partners with leading pharma firms including Amgen, AbbVie, GSK, and J&J.

Summary

OM1 is an Artificial Intelligence company based in Boston, United States, founded in 2015. Its most recent funding was a Series D round in Jul 2021. Investors include Polaris Partners, Scale Venture Partners and D1 Capital Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DJul 2021

Sign up to see all 4 rounds

Series A through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OM1 on Indexed.vc
<a href="https://indexed.vc/companies/om1"><img src="https://indexed.vc/api/badge/company/om1" alt="OM1 on Indexed.vc" width="260" height="76" /></a>